Founded in 2001 the company has grown steadily and operates out of modern laboratory facilities in Ongar, Essex, UK and Hopkinton, Massachusetts, USA.
Selcia has successfully completed 14C radiolabelled API projects on behalf of a diverse range of clients for phase 1 human trials, following MHRA GMP Certification in September 2010.
Selcia are proud to announce the publication of the latest posters on our proprietary CEfrag™ fragment screening technology and the Selcia Fragment Library.
It is with great sadness that we report the loss of two friends, Jim Little and Bruce Lowery.